{"name":"EpiBiologics","slug":"epibiologics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQSDdXUEthay1SWnl0Uk1IWUg2cEhSRU9BOS1vRnppZ1VvUUNGUkc4TzZlaGJYTVFYeHgwTDduRnVYS0ZWWC1XWGxES1ZCLWJSVmxlVkZLeHFNRTIwamZtVTY1TEozS1llb2VudTZodzYtT3pKeXBYYjhKWTJ1SGNSS1ZLTDloVWdPSkJuMkltamo0ZHhCWFFRelNPM204QU5YdThyY1BKanR4WlAyVUE?oc=5","date":"2026-01-12","type":"pipeline","source":"BioSpace","summary":"Early-Stage Biotechs Feel the Squeeze as Funding Favors Derisked Assets: JPM - BioSpace","headline":"Early-Stage Biotechs Feel the Squeeze as Funding Favors Derisked Assets: JPM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOaVUxRTFlZExpeDZ0YVlBX3hmd3lKM0xKNDFZSXpBSGNJX29tLXZveG9UTV80U3A4eldLbHRwMFVKRmk0LUhaSGtEY0xqMEN5d0hSejRONzZQcExvU0toaHJxT1hCVXIzRTZyU21ZTnRheXQ4cWhFNUdCTHo0X2NmQ3FB?oc=5","date":"2026-01-09","type":"pipeline","source":"geneonline.com","summary":"Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines - geneonline.com","headline":"Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPZlBPR2VUT21TTHY5TTNUNk0tcHRYSlNBcW0wVVVVQUlvbFRBUHlndFNKd3lEN2pTWERBX0xZZzFvRHYzLTFJZEtybWJHODdWalhHZ0RYQ1p5cEtzeWh1cGVuZnhGQkk5VkxDdFdkRFJhanl5TlVOTE4zZWQzZDZmQ2REcVN5MW5vMkdkTDVqZjg0R1dnUWhXSGZZUWY2d0U?oc=5","date":"2026-01-08","type":"pipeline","source":"BioPharma Dive","summary":"EpiBiologics raises $107M for its protein-degrading cancer drug - BioPharma Dive","headline":"EpiBiologics raises $107M for its protein-degrading cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQTTdzYU9qMndlMWNha01PaXg5dV9OekJBX011WlFKXzJBRm10ZzJaTFpERmlvUjJ5UXAxbFZkZ2RvQ0dHTzhEOXgxUnB5TmM0MURRZ0hiZ0wxcFViSkM5QTd3c0tCdEJTb2xOYTlrNC1CODlRQTA5V2NaVlozRk1MdFdMRmpBTnF4ZVljX0NtY3V0WXpfNl83UE9kc1ZxZUNo?oc=5","date":"2026-01-08","type":"pipeline","source":"statnews.com","summary":"EpiBiologics raises $107 million to develop bispecific antibodies against cancer and immune disorders - statnews.com","headline":"EpiBiologics raises $107 million to develop bispecific antibodies against cancer and immune disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE80cXNRM2tkM2tvLUdzYmEzMkNzZGRNZ09vaFd3LVJTUUFQRWZBX1VaM014bzQzQ0tNSXQtcmg3R0JMeG1mSi0yQzVQamJuY2tTWEFr?oc=5","date":"2026-01-08","type":"pipeline","source":"FirstWord Pharma","summary":"Biopharma bites: A flurry of financings headlined by Diagonal, plus updates from Servier, MoonLake - FirstWord Pharma","headline":"Biopharma bites: A flurry of financings headlined by Diagonal, plus updates from Servier, MoonLake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPUXdGN0FFX1NIbTMwZklTRTlYdllfcFFYcTV2ZDZUV3hYaFgwSWllZk1yV080cUNFcVlkbUNlLVJ5LVBOZVFIRmdFNFdSa3FMZl80cmJMUmpLYzQtT1c3MzhrZDUwd0lpc2IybDdSVUpPdzBISE9PNjJFaXVIM3pRRVhsWk5meVB3WEVKLW00LXdRODVRU1VnSnZRTkxlYXR5b1plbWNORk9jMk15?oc=5","date":"2026-01-08","type":"pipeline","source":"fiercebiotech.com","summary":"J&J, Google venture arms line up to back protein degradation biotech EpiBiologics' $107M series B - fiercebiotech.com","headline":"J&J, Google venture arms line up to back protein degradation biotech EpiBiologics' $107M series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNZENqc3RiQ2tnUmkxVHpwVXJPX25KMExSY3piS2I1X29FQldXXzFMc1QzTXE3dV9icjg4TzYwY19QRXBmWGtvNVkyT3VnanJPTk84SXF0S0FwN1JycWJiQUY4UWZUS0NZTU5yNGk1cFF2WEsxZ21sNHgyOFhkOVRUTjdzZXRZcF9yN3VUODB0RVkyUkJJMS1VUDdSMWt1dU1LbVE?oc=5","date":"2026-01-08","type":"pipeline","source":"fenwick.com","summary":"Fenwick Represents EpiBiologics in $107M Series B Funding - fenwick.com","headline":"Fenwick Represents EpiBiologics in $107M Series B Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxNcXJLaGFCUHkyU3llUzRENldUZm1TaWl1dkEtaXozeFk2R1RaZGJDQ1ZwYVc1eGRHb2U4aDZXd3Nld0h2Y2cwRmpZSTk1eS1VVXJMWFdaM2xTbjJyZHViLWRualdfN2VIZ0xhTk4yS3dUTHZUZVUxMVhJcWdEMTVTRk5Wd2sxVURGVVA3d0RIQjNTc3E3dDhBR2tFeGctSkxucG9BbjdZYlIyaDA2SXlVb25hRmhqMnVIMDJadHlITVM2UUFKWU50aGRaRThHbXAyTE9rb2c4ZWIwaWV6VkRBbnhnWXhZUWpmNnB2Z1c3YUtISHhTdjUwbW0wcFc5WVR5MkVtOVJVa0JyT1NLTFBMRGhuSkhIdE9vZUtWVUNxeGdDNnRYM1hoZlhpUVhsRi1FelVMSEktUlQxZzQtMGk4TVNrSzZsNjA?oc=5","date":"2026-01-08","type":"pipeline","source":"businesswire.com","summary":"EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology - businesswire.com","headline":"EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQV2xxNXRtdmpKYTJ3SE9vcGpabnprRUFlMDdOTlc1MFBuekljUEg4WTNGOVpQeXJyQUxSQjcyMEZNQXFHeHZPcUhDNE9uOFRubVcxMlpnR004UThWYUtJcWY0bjJweEdTTjNTWURlMl9JMnRLX0x6UGdvOXlXa21TU01uSkg0bnc5M2ZkYkJla2NKd0FEOElIQnlIdEI?oc=5","date":"2026-01-08","type":"deal","source":"Axios","summary":"EpiBiologics' $107m, Snowflake's buy, and Museum of Illusions changes hands - Axios","headline":"EpiBiologics' $107m, Snowflake's buy, and Museum of Illusions changes hands","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOUXBtc0pFVWVYY0duaTBHVjdnbUQ1RHc3MmdtdzRfSU4xeTlXUDRDaUJRVk5RelU3bk5lX3UzN1Z3ejVGX3NuelJZTm02RDlZVTBKWS1kQklXN2lmT0p5ZXFYbHZtTGVIMDhKVGZac3ZCc0ludjg3aE96VUVpOXdrUUxXdW1xQ2lWTlJUMUNJTVU2eWhocmktWQ?oc=5","date":"2026-01-08","type":"pipeline","source":"C&EN","summary":"Google, Johnson & Johnson back protein degrader start-up - C&EN","headline":"Google, Johnson & Johnson back protein degrader start-up - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOdUhaRFVacFN4cFE0TlN5UE1zX0Z2ZkNEMlM2bk56U043NnozUXcyZkZpTWVOVUhpMnc4aUZzNVlHMlBDeTdYSGlpdzZubHFobUFCLW96NXN6ZHB0ODd0dXhHNmRHckF5VGktNHdULWhwZmMxNExsNHVmWHNHdTd1ZklQYTM1RVpSbXBaelgySjNrX2VtSEE?oc=5","date":"2024-11-13","type":"pipeline","source":"C&EN","summary":"Big Pharma eyes a slew of molecular glues - C&EN","headline":"Big Pharma eyes a slew of molecular glues - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9BS3p5eHJHU0hxUGw0MVhqeVVURVNGS1hPNWNiLVJWUzdZMklfUjVONlZ3NE1qQ1FLQUhrcTFDQk5HODNHTW9PUE5SelF6b3pIZjNMZ3ZITXlfal9qYlJzX2d0ZEtCbHQ5Q3c?oc=5","date":"2024-07-07","type":"pipeline","source":"The Pharma Letter","summary":"EpiBiologics - The Pharma Letter","headline":"EpiBiologics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}